SHSE:600276'
s Quick Ratio Range Over the Past 10 Years
Min: 6.08 Med: 7.88 Max: 12.75
Current: 8.72
During the past 13 years, Jiangsu Hengrui Pharmaceuticals Co's highest Quick Ratio was 12.75. The lowest was 6.08. And the median was 7.88.
SHSE:600276's Quick Ratio is ranked better than 93.96% of 994
companies
in the Drug Manufacturers industry
Industry Median: 1.45
vs SHSE:600276: 8.72
Jiangsu Hengrui Pharmaceuticals Co (SHSE:600276) Quick Ratio Explanation
The quick ratio is more conservative than the Current Ratio because it excludes inventories from current assets. The ratio derives its name presumably from the fact that assets such as cash and marketable securities are quick sources of cash. Inventories generally take time to be converted into cash, and if they have to be sold quickly, the company may have to accept a lower price than book value of these inventories. As a result, they are justifiably excluded from assets that are ready sources of immediate cash.
In general, low or decreasing quick ratios generally suggest that a company is over-leveraged, struggling to maintain or grow sales, paying bills too quickly or collecting receivables too slowly. On the other hand, a high or increasing quick ratio generally indicates that a company is experiencing solid top-line growth, quickly converting receivables into cash, and easily able to cover its financial obligations. Such companies often have faster inventory turnover and cash conversion cycles.
The higher the quick ratio, the better the company's liquidity position.
Jiangsu Hengrui Pharmaceuticals Co Quick Ratio Related Terms
Jiangsu Hengrui Pharmaceuticals Co Quick Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Jiangsu Hengrui Pharmaceuticals Co Quick Ratio Chart
For the Drug Manufacturers - Specialty & Generic subindustry, Jiangsu Hengrui Pharmaceuticals Co's Quick Ratio, along with its competitors' market caps and Quick Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Jiangsu Hengrui Pharmaceuticals Co Quick Ratio vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Jiangsu Hengrui Pharmaceuticals Co's Quick Ratio distribution charts can be found below:
* The bar in red indicates where Jiangsu Hengrui Pharmaceuticals Co's Quick Ratio falls into.
Jiangsu Hengrui Pharmaceuticals Co Quick Ratio Calculation
The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. For this reason, the ratio excludes inventories from current assets.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Jiangsu Hengrui Pharmaceuticals Co (SHSE:600276) has a Quick Ratio of 8.72 as of Mar. 2026. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on Jiangsu Hengrui Pharmaceuticals Co and its competitors. This is 11% above median its historical median of 7.88. Over the past decade, Jiangsu Hengrui Pharmaceuticals Co's Quick Ratio has ranged from 6.08 to 12.75. According to the industry distribution chart, Jiangsu Hengrui Pharmaceuticals Co ranks #60 out of 994 companies in the Drug Manufacturers industry, placing it in the top 6%.
Is Jiangsu Hengrui Pharmaceuticals Co's Quick Ratio too high?
Jiangsu Hengrui Pharmaceuticals Co's current Quick Ratio of 8.72 is 11% above median its 10-year median of 7.88. Over the past 10 years, this metric has ranged from a low of 6.08 to a high of 12.75. The Drug Manufacturers industry median Quick Ratio is 1.45. Jiangsu Hengrui Pharmaceuticals Co's value of 8.72 is 501.4% above this industry median. Based on the distribution chart, Jiangsu Hengrui Pharmaceuticals Co ranks #60 out of 994 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Jiangsu Hengrui Pharmaceuticals Co has a GF Score™ of 91/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Jiangsu Hengrui Pharmaceuticals Co's Quick Ratio compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Jiangsu Hengrui Pharmaceuticals Co ranks #60 out of 994 companies for Quick Ratio. This places Jiangsu Hengrui Pharmaceuticals Co in the top 6% of its industry — outperforming the majority of peers. The industry median Quick Ratio is 1.45. Jiangsu Hengrui Pharmaceuticals Co's value of 8.72 is 501.4% above this benchmark. Historically, Jiangsu Hengrui Pharmaceuticals Co's own Quick Ratio has ranged from 6.08 to 12.75 over the past decade. While the company's 10-year median is 7.88 vs. the industry median of 1.45, Jiangsu Hengrui Pharmaceuticals Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Quick Ratio for a Drug Manufacturers company?
The median Quick Ratio among Drug Manufacturers companies is 1.45, based on 994 companies in the industry. Companies in the top quartile (top 25%) have a Quick Ratio significantly above this median, while those in the bottom quartile fall well below. However, Quick Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Jiangsu Hengrui Pharmaceuticals Co's current Quick Ratio of 8.72 is 501.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Quick Ratio mean?
A high Quick Ratio can signal that a stock is expensive relative to its fundamentals. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on Jiangsu Hengrui Pharmaceuticals Co and its competitors. For the Drug Manufacturers industry, the median Quick Ratio is 1.45 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Jiangsu Hengrui Pharmaceuticals Co's current Quick Ratio is 8.72, which is 11% above median its own 10-year median of 7.88. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Jiangsu Hengrui Pharmaceuticals Co stock overvalued right now?
Based on GuruFocus' analysis, Jiangsu Hengrui Pharmaceuticals Co (SHSE:600276) is currently considered Modestly Undervalued. The stock's GF Value™ is ¥60.54, compared to a current price of ¥54.45 — trading 10.1% below its estimated fair value. The current Quick Ratio is 8.72, which is 11% above median its 10-year median of 7.88 and 501.4% above the Drug Manufacturers industry median of 1.45. Jiangsu Hengrui Pharmaceuticals Co's overall GF Score™ is 91/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Quick Ratio calculated?
Quick Ratio is calculated from a company's financial statements. For Jiangsu Hengrui Pharmaceuticals Co (SHSE:600276), the current Quick Ratio is 8.72 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Jiangsu Hengrui Pharmaceuticals Co (SHSE:600276) Overvalued in 2026?
Based on GuruFocus' analysis, Jiangsu Hengrui Pharmaceuticals Co stock appears to be undervalued.
The current stock price of ¥54.45 is trading 10.1% below its estimated GF Value™ of ¥60.54.
GuruFocus considers Jiangsu Hengrui Pharmaceuticals Co to be Modestly Undervalued.
Key valuation signals for SHSE:600276:
Quick Ratio: 8.72 (11% above median its 10-year median of 7.88)
GF Value™: ¥60.54 vs. price of ¥54.45 (10.1% below fair value)
Industry Position: 501.4% above the Drug Manufacturers median (#60 of 994)
No single metric tells the full story. See the SHSE:600276 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Jiangsu Hengrui Pharmaceuticals Co Business Description
Jiangsu Hengrui Pharmaceuticals Co Ltd is a biopharmaceutical company that engages in the research, development, manufacture, and sale of drugs. It is engaged in the field of cancer treatment drugs, surgical medicines, endocrine therapy drugs, cardiovascular drugs, and anti-infection medications. The company specializes in the research and development of new medicines in areas of antineoplastics, endocrine system, cardiovascular, and the immune system. Geographically, the company is segmented as Chinese mainland and Other countries generating majority revenue from the Chinese region.
91GF Score
Get the complete analysis for SHSE:600276
Quick Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:600276 has been successfully added to your 
